Shengmei Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shengmei Zhou has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Cheng Zhang
School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
1 shared publication - Guoming Chen
School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China
1 shared publication - Jiayi Zou
First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
1 shared publication - Ning Wang
The University of Hong Kong
1 shared publication - Qianhua He
First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
1 shared publication - Qili Xiao
Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
1 shared publication
Latest Publications
- Open Access
The Role of Non-Coding RNAs in Regulating Cachexia Muscle Atrophy
Cachexia is a late consequence of various diseases that is characterized by systemic muscle loss, with or without fat loss, leading to significant mortality. Multiple signaling pathways and molecules that increase catabolism, decrease anabolism, and interfere with muscle regeneration are activated. Non-coding RNAs (ncRNAs), such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), play vital roles in cachexia muscle atrophy. This review mainly provides the mechanisms of specific ncRNAs to regulate muscle loss during cachexia and discusses the role of ncRNAs in cachectic biomarkers and novel therapeutic strategies that could offer new insights for clinical practice.
Open AccessThe Role of Non-Coding RNAs in Regulating Cachexia Muscle Atrophy
Cachexia is a late consequence of various diseases that is characterized by systemic muscle loss, with or without fat loss, leading to significant mortality. Multiple signaling pathways and molecules that increase catabolism, decrease anabolism, and interfere with muscle regeneration are activated. Non-coding RNAs (ncRNAs), such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), play vital roles in cachexia muscle atrophy. This review mainly provides the mechanisms of specific ncRNAs to regulate muscle loss during cachexia and discusses the role of ncRNAs in cachectic biomarkers and novel therapeutic strategies that could offer new insights for clinical practice.